Recent Research Analysts’ Ratings Changes for GoDaddy (GDDY)
A number of research firms have changed their ratings and price targets for GoDaddy (NYSE: GDDY): 10/31/2025 – GoDaddy had its “strong-buy” rating reaffirmed by analysts at Raymond James Financial, Inc.. 10/31/2025 – GoDaddy had its “neutral” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $150.00 price target on the stock. 10/31/2025 […]
Research Analysts’ Weekly Ratings Updates for RB Global (RBA)
Several analysts have recently updated their ratings and price targets for RB Global (NYSE: RBA): 11/8/2025 – RB Global was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating. 11/7/2025 – RB Global had its price target raised by analysts at Royal Bank Of Canada from $132.00 to $133.00. […]
Cameco (CCO) – Research Analysts’ Weekly Ratings Updates
Cameco (TSE: CCO) recently received a number of ratings updates from brokerages and research firms: 11/13/2025 – Cameco had its price target lowered by analysts at Royal Bank Of Canada from C$160.00 to C$150.00. 11/13/2025 – Cameco had its price target raised by analysts at TD Securities from C$142.00 to C$150.00. 11/10/2025 – Cameco was […]
Recent Investment Analysts’ Ratings Updates for ACV Auctions (ACVA)
ACV Auctions (NASDAQ: ACVA) has recently received a number of price target changes and ratings updates: 11/11/2025 – ACV Auctions is now covered by analysts at Barclays PLC. They set an “equal weight” rating and a $6.00 price target on the stock. 11/7/2025 – ACV Auctions had its price target lowered by analysts at The […]
Analysts’ Recent Ratings Updates for Installed Building Products (IBP)
A number of research firms have changed their ratings and price targets for Installed Building Products (NYSE: IBP): 11/10/2025 – Installed Building Products was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating. 11/6/2025 – Installed Building Products was given a new $265.00 price target on by analysts at […]
Collegium Pharmaceutical (COLL) – Investment Analysts’ Recent Ratings Changes
A number of firms have modified their ratings and price targets on shares of Collegium Pharmaceutical (NASDAQ: COLL) recently: 11/8/2025 – Collegium Pharmaceutical was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating. 11/7/2025 – Collegium Pharmaceutical had its price target raised by analysts at Truist Financial Corporation from […]
last updated on 14 Nov 06:45